Acacia Pharma is an England-based pharmaceutical company that develops and commercializes novel products for cancer chemotherapy.
Business Model:
Revenue: $211k
Employees: 51-200
Acacia Pharma was acquired by
Eagle Pharmaceuticals.
The acquisition happend on 2022-03-28.
Details of the transaction were not public
Address: Royston Road
City: Cambridge
State: england
Zip: CB22 4QH
Country: GB
Acacia Pharma is an England-based pharmaceutical company that develops and commercializes novel products for cancer chemotherapy.
Contact Phone:
Contact Email:
Listed Exchange:
Other
IPO Date:
2/21/2018
Ticker Symbol:
ACPH
IPO Price:
$4.4210347923157505/share
Amount Raised:
$49M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2020 | Cosmo Pharmaceuticals | Post-IPO Debt | 25M |
6/2020 | Cosmo Pharmaceuticals | Post-IPO Debt | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2013 | Series B | 5 | $23.5M |
Novo Holdings Eight Roads Ventures F-Prime Capital Lundbeckfonden Ventures Gilde Healthcare F-Prime Capital Novo Holdings Novo Holdings Eight Roads Ventures F-Prime Capital Lundbeckfonden Ventures Gilde Healthcare F-Prime Capital Novo Holdings |
3/2011 | Series A | 2 | $10M |
Lundbeckfonden Ventures Gilde Healthcare Lundbeckfonden Ventures Lundbeckfonden Ventures Gilde Healthcare Lundbeckfonden Ventures |
7/2018 | Debt Financing | 1 | $30M |
Hercules Capital Hercules Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|